Key words: coronary artery disease, coronary flow reserve, dobutamine stress echocardiography, Doppler myocardial imaging, ischemic heart disease, myocardial ischemia What the eye doesn't see and the mind doesn't know, doesn't exist.-D.H. Lawrence, Lady Chatterley's Lover Dobutamine stress echocardiography (DSE) is the holy grail of functional diagnosis of coronary artery disease by noninvasive imaging. Although the heart can be put on pharmacological stress during cardiac magnetic resonance, positron emission tomography, or other kind of hybrid and nonhybrid imaging, echocardiography has been the quintessential, cheap, and bedside modality practiced in practically all parts of the world either for de novo diagnosis of coronary artery disease (CAD) or to assess the reversible myocardial ischemia in preexistent, revascularized coronary heart disease with variable left ventricular functional status. More recently, DSE has also been recommended in noncoronary artery diseases, such as in valvular heart disease, dilated cardiomyopathy, and other clinical situations. 1 Although DSE has been in clinical practice for decades, the modality still suffers from issues of sensitivity so much so that not only the accuracy but also the inter-observer agreements may remain low. 2 Interpretation of DSE is also dependent on the image quality and on the extent and number of coronary arteries involved. 2,3 Moreover, inter-institutional observer agreement for reading of regional wall motion abnormality is at best suboptimal and at worst poor even using high-quality imaging. 3 To circumvent the subjective component of reading wall motion status during DSE, the 1st ever European multicenter MYDISE (Myocardial Doppler in Stress Echocardiography) study has shown that application of offline postprocessing on the digitally acquired DSE cine loops from patients suffering from chest pain can vastly improve the sensitivity and specificity of DSE, quantified by velocity imaging, using tissue Doppler echocardiography. 4 A subsequent substudy has also shown that in circumflex territory ischemia, displacement-based tissue tracking could also improve the sensitivity and specificity 5 for detection of the circumflex disease. The same group has extended the application to patients with diabetes with or without concomitant coronary artery disease and hypertension, 6,7 and has shown that myocardial contractile reserve is compromised in isolated type 2 diabetes and the deterioration becomes much more pronounced in presence of concomitant coronary artery disease and/or hypertension. Despite the apparent success of velocity-based imaging, concern was raised about the limitations of velocity imaging because of the effect of so-called tethering and translational motion of the myocardium. Strain (velocity differential over a finite distance) imaging began to emerge subsequently that resulted in better quantification of DSE to an extent that the quantification of DSE by strain rate imaging was proclaimed to be "strain without pain" because of the superb deli...